MedAlliance Swiss Medical Technology
Medical Equipment ManufacturingVaud, Switzerland51-200 Employees
MedAlliance is a privately owned medical technology company focused on developing and commercializing drug-device combination products for treating coronary and peripheral artery disease. It is headquartered in Nyon, Vaud, Switzerland, with additional offices in Germany, Singapore, the United Kingdom, and the United States. The company’s flagship SELUTION SLR balloon catheter delivers sirolimus in a controlled, sustained manner using MicroReservoirs built from a biodegradable polymer and a coating strategy that adheres to the balloon and vessel lumen. Since its founding in 2008, MedAlliance has pursued regulatory milestones in its target markets, including FDA Breakthrough Device Designation in 2019 for a coronary drug-eluting balloon and CE Mark approvals in 2020 for peripheral arterial disease and for coronary disease. The company’s products are aimed at clinicians in interventional cardiology and peripheral vascular care seeking alternatives to reduce restenosis in treated vessels. In recent coverage, MedAlliance is noted for ongoing development of Selution SLR, reflecting continued activity in sustained drug-release therapy for vascular diseases.
1-888-653-2347 
support@leadiq.com 
